Eficacia y seguridad de biopsia de próstatafusión con software transperineal

Jonathan  Delgado-Saavedra; Ronald  Mayorga- Palacios; Marco  Vásquez-Morales; Emperatriz E.  Centeno-Martinez

doi:10.56838/icmed.v14i4.225

Authors

Jonathan Delgado-Saavedra Clínica Obra de San Camilo, Lima - Perú. https://orcid.org/0009-0009-7182-1168
Ronald Mayorga- Palacios Clínica Obra de San Camilo, Lima - Perú. https://orcid.org/0009-0005-4195-2213
Marco Vásquez-Morales Servicio de Urología, Clínica Internacional, Lima - Perú. https://orcid.org/0009-0004-8623-3039
Emperatriz E. Centeno-Martinez Clínica Obra de San Camilo, Lima - Perú https://orcid.org/0009-0006-9978-6542

DOI:

https://doi.org/10.56838/icmed.v14i4.225

Keywords:

prostate biopsy, image fusion, multiparametric MRI, prostate cancer, patient safety

Abstract

Purpuse: To evaluate the efficacy and safety of software-guided transperineal prostate biopsy fusion in detecting prostate
cancer compared to conventional techniques. Methods: Descriptive, observational, and retrospective study in 100 patients
over 40 years old with PIRADS ≥ 3 and PSA < 20, undergoing transperineal prostate biopsy fusion at Clínica Internacional from
November 2022 to June 2023. Diagnostic accuracy and cancer detection rates were analyzed. Results: The average age was
67.6 years. The cancer detection rate was 71%, and 49% for clinically significant prostate cancer (CSPC). Complications were
minimal (2%). The fusion technique significantly improved diagnostic accuracy compared to conventional transrectal biopsies. Discussion: Software-guided transperineal biopsy fusion showed high efficacy in detecting CSPC, superior to conventional techniques, with a low complication rate. The precision in identifying suspicious areas through image fusion improves cancer detection. Conclusions: Software-guided transperineal prostate biopsy fusion is a safe and effective technique for prostate cancer detection, improving diagnostic accuracy and reducing complications compared to conventional techniques.